0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Canine Flu Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-2I13541
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Canine Flu Therapeutics Market Research Report 2023
BUY CHAPTERS

Canine Flu Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-2I13541
Report
September 2024
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Canine Flu Therapeutics - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Canine Flu Therapeutics - Market

Canine Flu Therapeutics - Market

Canine flu, which is also called dog flu; is a contagious disease that affects the dog’s respiratory system. It is mainly caused by canine influenza virus/Type An influenza virus. There are two types of influenza viruses H3N2 virus H3N8 virus.
The global market for Canine Flu Therapeutics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Canine Flu Therapeutics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Canine Flu Therapeutics by region & country, by Type, and by Application.
The Canine Flu Therapeutics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Canine Flu Therapeutics.
Market Segmentation

Scope of Canine Flu Therapeutics - Market Report

Report Metric Details
Report Name Canine Flu Therapeutics - Market
CAGR 5%
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck & Co, Intervet, Zoetis Services
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Canine Flu Therapeutics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Canine Flu Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Canine Flu Therapeutics in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Canine Flu Therapeutics - Market report?

Ans: The main players in the Canine Flu Therapeutics - Market are Merck & Co, Intervet, Zoetis Services

What are the Application segmentation covered in the Canine Flu Therapeutics - Market report?

Ans: The Applications covered in the Canine Flu Therapeutics - Market report are Vet Clinics, Veterinary Hospitals, Animal Healthcare Facilities

What are the Type segmentation covered in the Canine Flu Therapeutics - Market report?

Ans: The Types covered in the Canine Flu Therapeutics - Market report are Vaccines, Others

Recommended Reports

Dog Therapeutics

Veterinary Pharmaceuticals

Flu & Vaccine Markets

1 Market Overview
1.1 Canine Flu Therapeutics Product Introduction
1.2 Global Canine Flu Therapeutics Market Size Forecast
1.3 Canine Flu Therapeutics Market Trends & Drivers
1.3.1 Canine Flu Therapeutics Industry Trends
1.3.2 Canine Flu Therapeutics Market Drivers & Opportunity
1.3.3 Canine Flu Therapeutics Market Challenges
1.3.4 Canine Flu Therapeutics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Canine Flu Therapeutics Players Revenue Ranking (2023)
2.2 Global Canine Flu Therapeutics Revenue by Company (2019-2024)
2.3 Key Companies Canine Flu Therapeutics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Canine Flu Therapeutics Product Offered
2.5 Key Companies Time to Begin Mass Production of Canine Flu Therapeutics
2.6 Canine Flu Therapeutics Market Competitive Analysis
2.6.1 Canine Flu Therapeutics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Canine Flu Therapeutics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Flu Therapeutics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Vaccines
3.1.2 Others
3.2 Global Canine Flu Therapeutics Sales Value by Type
3.2.1 Global Canine Flu Therapeutics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Canine Flu Therapeutics Sales Value, by Type (2019-2030)
3.2.3 Global Canine Flu Therapeutics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Vet Clinics
4.1.2 Veterinary Hospitals
4.1.3 Animal Healthcare Facilities
4.2 Global Canine Flu Therapeutics Sales Value by Application
4.2.1 Global Canine Flu Therapeutics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Canine Flu Therapeutics Sales Value, by Application (2019-2030)
4.2.3 Global Canine Flu Therapeutics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Canine Flu Therapeutics Sales Value by Region
5.1.1 Global Canine Flu Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Canine Flu Therapeutics Sales Value by Region (2019-2024)
5.1.3 Global Canine Flu Therapeutics Sales Value by Region (2025-2030)
5.1.4 Global Canine Flu Therapeutics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Canine Flu Therapeutics Sales Value, 2019-2030
5.2.2 North America Canine Flu Therapeutics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Canine Flu Therapeutics Sales Value, 2019-2030
5.3.2 Europe Canine Flu Therapeutics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Canine Flu Therapeutics Sales Value, 2019-2030
5.4.2 Asia Pacific Canine Flu Therapeutics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Canine Flu Therapeutics Sales Value, 2019-2030
5.5.2 South America Canine Flu Therapeutics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Canine Flu Therapeutics Sales Value, 2019-2030
5.6.2 Middle East & Africa Canine Flu Therapeutics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Canine Flu Therapeutics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Canine Flu Therapeutics Sales Value
6.3 United States
6.3.1 United States Canine Flu Therapeutics Sales Value, 2019-2030
6.3.2 United States Canine Flu Therapeutics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Canine Flu Therapeutics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Canine Flu Therapeutics Sales Value, 2019-2030
6.4.2 Europe Canine Flu Therapeutics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Canine Flu Therapeutics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Canine Flu Therapeutics Sales Value, 2019-2030
6.5.2 China Canine Flu Therapeutics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Canine Flu Therapeutics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Canine Flu Therapeutics Sales Value, 2019-2030
6.6.2 Japan Canine Flu Therapeutics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Canine Flu Therapeutics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Canine Flu Therapeutics Sales Value, 2019-2030
6.7.2 South Korea Canine Flu Therapeutics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Canine Flu Therapeutics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Canine Flu Therapeutics Sales Value, 2019-2030
6.8.2 Southeast Asia Canine Flu Therapeutics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Canine Flu Therapeutics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Canine Flu Therapeutics Sales Value, 2019-2030
6.9.2 India Canine Flu Therapeutics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Canine Flu Therapeutics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Merck & Co
7.1.1 Merck & Co Profile
7.1.2 Merck & Co Main Business
7.1.3 Merck & Co Canine Flu Therapeutics Products, Services and Solutions
7.1.4 Merck & Co Canine Flu Therapeutics Revenue (US$ Million) & (2019-2024)
7.1.5 Merck & Co Recent Developments
7.2 Intervet
7.2.1 Intervet Profile
7.2.2 Intervet Main Business
7.2.3 Intervet Canine Flu Therapeutics Products, Services and Solutions
7.2.4 Intervet Canine Flu Therapeutics Revenue (US$ Million) & (2019-2024)
7.2.5 Intervet Recent Developments
7.3 Zoetis Services
7.3.1 Zoetis Services Profile
7.3.2 Zoetis Services Main Business
7.3.3 Zoetis Services Canine Flu Therapeutics Products, Services and Solutions
7.3.4 Zoetis Services Canine Flu Therapeutics Revenue (US$ Million) & (2019-2024)
7.3.5 Recent Developments
8 Industry Chain Analysis
8.1 Canine Flu Therapeutics Industrial Chain
8.2 Canine Flu Therapeutics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Canine Flu Therapeutics Sales Model
8.5.2 Sales Channel
8.5.3 Canine Flu Therapeutics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Canine Flu Therapeutics Market Trends
    Table 2. Canine Flu Therapeutics Market Drivers & Opportunity
    Table 3. Canine Flu Therapeutics Market Challenges
    Table 4. Canine Flu Therapeutics Market Restraints
    Table 5. Global Canine Flu Therapeutics Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Canine Flu Therapeutics Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Canine Flu Therapeutics Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Canine Flu Therapeutics Product Type
    Table 9. Key Companies Time to Begin Mass Production of Canine Flu Therapeutics
    Table 10. Global Canine Flu Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Flu Therapeutics as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Canine Flu Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Canine Flu Therapeutics Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Canine Flu Therapeutics Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Canine Flu Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Canine Flu Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Canine Flu Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Canine Flu Therapeutics Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Canine Flu Therapeutics Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Canine Flu Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Canine Flu Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Canine Flu Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Canine Flu Therapeutics Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Canine Flu Therapeutics Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Canine Flu Therapeutics Sales Value by Region (2019-2024) & (%)
    Table 27. Global Canine Flu Therapeutics Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Canine Flu Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Canine Flu Therapeutics Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Canine Flu Therapeutics Sales Value, (2025-2030) & (US$ Million)
    Table 31. Merck & Co Basic Information List
    Table 32. Merck & Co Description and Business Overview
    Table 33. Merck & Co Canine Flu Therapeutics Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Canine Flu Therapeutics Business of Merck & Co (2019-2024)
    Table 35. Merck & Co Recent Developments
    Table 36. Intervet Basic Information List
    Table 37. Intervet Description and Business Overview
    Table 38. Intervet Canine Flu Therapeutics Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Canine Flu Therapeutics Business of Intervet (2019-2024)
    Table 40. Intervet Recent Developments
    Table 41. Zoetis Services Basic Information List
    Table 42. Zoetis Services Description and Business Overview
    Table 43. Zoetis Services Canine Flu Therapeutics Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Canine Flu Therapeutics Business of Zoetis Services (2019-2024)
    Table 45. Zoetis Services Recent Developments
    Table 46. Key Raw Materials Lists
    Table 47. Raw Materials Key Suppliers Lists
    Table 48. Canine Flu Therapeutics Downstream Customers
    Table 49. Canine Flu Therapeutics Distributors List
    Table 50. Research Programs/Design for This Report
    Table 51. Key Data Information from Secondary Sources
    Table 52. Key Data Information from Primary Sources
    Table 53. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Canine Flu Therapeutics Product Picture
    Figure 2. Global Canine Flu Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Canine Flu Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 4. Canine Flu Therapeutics Report Years Considered
    Figure 5. Global Canine Flu Therapeutics Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Canine Flu Therapeutics Revenue in 2023
    Figure 7. Canine Flu Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Vaccines Picture
    Figure 9. Others Picture
    Figure 10. Global Canine Flu Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Canine Flu Therapeutics Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Vet Clinics
    Figure 13. Product Picture of Veterinary Hospitals
    Figure 14. Product Picture of Animal Healthcare Facilities
    Figure 15. Global Canine Flu Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Canine Flu Therapeutics Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Canine Flu Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Canine Flu Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Canine Flu Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Canine Flu Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Canine Flu Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Canine Flu Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Canine Flu Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Canine Flu Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Canine Flu Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Canine Flu Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Canine Flu Therapeutics Sales Value (%), (2019-2030)
    Figure 28. United States Canine Flu Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Canine Flu Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Canine Flu Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Canine Flu Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Canine Flu Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Canine Flu Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Canine Flu Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Canine Flu Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Canine Flu Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Canine Flu Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Canine Flu Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Canine Flu Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Canine Flu Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Canine Flu Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Canine Flu Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Canine Flu Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Canine Flu Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Canine Flu Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Canine Flu Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Canine Flu Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Canine Flu Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 49. Canine Flu Therapeutics Industrial Chain
    Figure 50. Canine Flu Therapeutics Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart